BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2022 12:54:50 PM | Browse: 631 | Download: 2178
 |
Received |
|
2022-05-19 16:17 |
|
Peer-Review Started |
|
2022-05-19 16:20 |
|
First Decision by Editorial Office Director |
|
2022-06-06 06:37 |
|
Return for Revision |
|
2022-06-06 13:44 |
|
Revised |
|
2022-06-20 18:35 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-09-19 03:46 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-09-21 18:05 |
|
Articles in Press |
|
2022-09-21 18:05 |
|
Edit the Manuscript by Language Editor |
|
2022-09-07 13:20 |
|
Typeset the Manuscript |
|
2022-09-27 15:55 |
|
Publish the Manuscript Online |
|
2022-10-14 12:54 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
Overexpression of ELL-associated factor 2 suppresses invasion, migration, and angiogenesis in colorectal cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ming-Liang Feng, Can Wu, Hui-Jing Zhang, Huan Zhou, Tai-Wei Jiao, Meng-Yuan Liu and Ming-Jun Sun |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Foundation of Liaoning Province |
2019-BS-279 |
|
| Corresponding Author |
Ming-Jun Sun, Doctor, PhD, Chief Physician, Professor, Department of Endoscopy, The First Hospital Affiliated to China Medical University, No. 155 Nanjing North Street, Shenyang 110001, Liaoning Province, China. sunydyy@163.com |
| Key Words |
ELL-associated factor 2; Transforming growth factor-β1; Signal transducer and activator of transcription 3; Colorectal cancer; Invasion; Migration; Angiogenesis |
| Core Tip |
Androgen-responsive gene ELL-associated factor 2 (EAF2) plays an important role in tumor suppression in a variety of malignant tumors. We found that EAF2 protein was lowly expressed in colorectal cancer (CRC) tissues. Kaplan-Meier survival analysis showed that the survival rate of the group with high EAF2 level was higher than that of the group with low EAF2 level. Moreover, EAF2 may play a tumor suppressive and protective role in CRC by inhibiting the invasion, metastasis, and angiogenesis via regulating the signal transducer and activator of transcription 3/transforming growth factor beta 1 crosstalk pathway. Our findings are of great significance to provide a new idea and theoretical basis for targeting diagnosis and therapy of CRC. |
| Publish Date |
2022-10-14 12:54 |
| Citation |
Feng ML, Wu C, Zhang HJ, Zhou H, Jiao TW, Liu MY, Sun MJ. Overexpression of ELL-associated factor 2 suppresses invasion, migration, and angiogenesis in colorectal cancer. World J Gastrointest Oncol 2022; 14(10): 1949-1967 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i10/1949.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i10.1949 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
